---
figid: PMC3309723__pnas.1108595109fig5
figtitle: Parp1 mediation of Sox2 activity in ESC pluripotency
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC3309723
filename: pnas.1108595109fig5.jpg
figlink: /pmc/articles/PMC3309723/figure/F5/
number: F5
caption: Model for Parp1 mediation of Sox2 activity in ESC pluripotency. In ESCs,
  Sox2 is preferentially activated by Klf4 in response to LIF/Jak/Stat3 signaling.
  On the other hand, Sox2 is negatively regulated by Parp1 auto-PARylation in response
  to the FGF/ERK pathway. These opposing signals maintain Sox2 at levels that optimally
  maintain ESC pluripotency.
papertitle: SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase
  1 (Parp1) complexes regulate pluripotency.
reftext: Yi-Shin Lai, et al. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3772-3777.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8926947
figid_alias: PMC3309723__F5
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC3309723__F5
ndex: 04c9c9c5-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3309723__pnas.1108595109fig5.html
  '@type': Dataset
  description: Model for Parp1 mediation of Sox2 activity in ESC pluripotency. In
    ESCs, Sox2 is preferentially activated by Klf4 in response to LIF/Jak/Stat3 signaling.
    On the other hand, Sox2 is negatively regulated by Parp1 auto-PARylation in response
    to the FGF/ERK pathway. These opposing signals maintain Sox2 at levels that optimally
    maintain ESC pluripotency.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lif
  - Lifr
  - Afg3l2
  - Parp1
  - Stat3
  - Plxna3
  - Parg
  - Kif4
  - Sox2
  - Qsox1
  - Nanog
  - Fgf4
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - LIF
  - NR1I2
  - JTB
  - PARP1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - PARG
  - KIF4A
  - SOX2
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - NANOG
  - Cancer
---
